SEC Form 4 · accession 0000886163-15-000064

LIGAND PHARMACEUTICALS INC · LGND

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — VP, Finance & Strategy and CFO

Period of report

May 12, 2015

Accepted (ET)

May 14, 2015 · 5:39 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000886163

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	May 12, 2015	M	14,214	$14.47	A	36,496	D
Common Stock	May 12, 2015	S	14,214	$84.44	D	22,282	D
Common Stock	May 12, 2015	M	9,306	$21.92	A	31,588	D
Common Stock	May 12, 2015	S	9,306	$84.91	D	22,282	D
Common Stock	May 13, 2015	M	12,148	$21.92	A	34,430	D
Common Stock	May 13, 2015	S	12,148	$83.23	D	22,282	D
Common Stock	May 13, 2015	M	11,757	$14.47	A	34,039	D
Common Stock	May 13, 2015	S	11,757	$83.32	D	22,282	D
Common Stock	May 14, 2015	M	20,938	$74.42	A	43,220	D
Common Stock	May 14, 2015	S	20,938	$83.84	D	22,282	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F1	$14.47	May 12, 2015	M	14,214	D	—	Feb 9, 2022	Common Stock	14,214	75,786	D
Employee Stock Option (right to buy)^F1	$14.47	May 13, 2015	M	11,757	D	—	Feb 9, 2022	Common Stock	11,757	64,029	D
Employee Stock Option (right to buy)^F2	$21.92	May 12, 2015	M	9,306	D	—	Feb 15, 2023	Common Stock	9,306	35,694	D
Employee Stock Option (right to buy)^F2	$21.92	May 13, 2015	M	12,148	D	—	Feb 15, 2023	Common Stock	12,148	23,546	D
Employee Stock Option (right to buy)^F3	$74.42	May 14, 2015	M	20,938	D	—	Feb 12, 2024	Common Stock	20,938	24,062	D

F1Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/09/12.
F2Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/15/13.
F3Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/12/14.